Assessment of Implantable Cardioverter-Defibrillator Used in Heart Failure with Reduced Ejection Fraction as Primary Prevention in an Underserved Population

被引：0
|
作者：
Lu, Yifan [1 ]
Wan, Ningxin [1 ]
Madan, Nidhi [1 ]
Hovnanians, Ninel [1 ]
Diaz, Juan Carlos Ruiz [1 ]
Christia, Panagiota [1 ]
Faillace, Robert [1 ]
机构：
[1] Albert Einstein Coll Med, Jacobi Med Ctr, Bronx, NY 10467 USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2018年 / 33卷 / 11期
关键词：
THERAPY;
D O I：
10.1007/s11606-018-4544-1
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：1854 / 1856
页数：3
相关论文
共 50 条
  • [41] The Timing of Implantable Cardioverter-Defibrillator Implantation in Patients with Heart Failure
    Nawaf S. Al-Majed
    Justin A. Ezekowitz
    Current Cardiology Reports, 2012, 14 : 299 - 307
  • [42] Evaluating systemic immune-inflammation index in patients with implantable cardioverter defibrillator for heart failure with reduced ejection fraction
    Hayiroglu, Mert Ilker
    Cinar, Tufan
    Cinier, Goksel
    Pay, Levent
    Yumurtas, Ahmet Cagdas
    Tezen, Ozan
    Eren, Semih
    Kolak, Zeynep
    Cetin, Tugba
    Cicek, Vedat
    Tekkesin, Ahmet Ilker
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2022, 45 (02): : 188 - 195
  • [43] Functional Classes of Heart Failure and Indications for Implantable Cardioverter-Defibrillator
    Guglin, Maya
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 122 (01): : 182 - 182
  • [44] Evaluating systemic immune-inflammation index in patients with implantable cardioverter defibrillator for heart failure with reduced ejection fraction
    Hayiroglu, M.
    Cinar, T.
    Cinier, G.
    Pay, L.
    Yumurtas, A. C.
    Tezen, O.
    Eren, S.
    Kolak, Z.
    Cetin, T.
    Cicek, V.
    Tekkesin, A. I.
    EUROPEAN HEART JOURNAL, 2022, 43 : 996 - 996
  • [45] Mortality among ischemic and nonischemic heart failure patients with a primary implantable cardioverter-defibrillator
    Yang, Pil-Sung
    Kang, Younghyun
    Bae, Han-Joon
    Sung, Jung-Hoon
    Park, Hyung-Deuk
    Joung, Boyoung
    JOURNAL OF ARRHYTHMIA, 2021, 37 (06) : 1537 - 1545
  • [46] Heart Rate Predicts Outcomes in an Implantable Cardioverter-Defibrillator Population
    Ahmadi-Kashani, Mastaneh
    Kessler, David J.
    Day, John
    Bunch, T. Jared
    Stolen, Kira Q.
    Brown, Scott
    Sbaity, Salam
    Olshansky, Brian
    CIRCULATION, 2009, 120 (21) : 2040 - 2045
  • [47] Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Not everyone with an ejection fraction less than or equal to 30% should receive an implantable cardioverter-defibrillator - Response
    Moss, AJ
    CIRCULATION, 2005, 111 (19) : 2549 - 2549
  • [48] Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Everyone with an ejection fraction less than or equal to 30% should receive an implantable cardioverter-defibrillator - Response
    Buxton, AE
    CIRCULATION, 2005, 111 (19) : 2548 - 2548
  • [49] Comparison and predictors of implantable cardioverter-defibrillator therapy for primary and secondary prevention
    Reinder Evertz
    Tessa van der Heijden
    Rypko Beukema
    Sjoerd Westra
    Esther Meindersma
    Caroline van Deursen
    Kevin Vernooy
    Netherlands Heart Journal, 2023, 31 : 348 - 356
  • [50] Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes
    Sharma, Abhinav
    Al-Khatib, Sana M.
    Ezekowitz, Justin A.
    Cooper, Lauren B.
    Fordyce, Christopher B.
    Felker, G. Michael
    Bardy, Gust H.
    Poole, Jeanne E.
    Bigger, J. Thomas
    Buxton, Alfred E.
    Moss, Arthur J.
    Friedman, Daniel J.
    Lee, Kerry L.
    Steinman, Richard
    Dorian, Paul
    Cappato, Riccardo
    Kadish, Alan H.
    Kudenchuk, Peter J.
    Mark, Daniel B.
    Peterson, Eric D.
    Inoue, Lurdes Y. T.
    Sanders, Gillian D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (06) : 1031 - 1038
12345